Facing Slower Growth, Health Insurer Centene Pulls 2025 Profit Outlook
Health insurer Centene, one of the nation's biggest providers of individual coverage under the Affordable Care Act known as Obamacare, on Tuesday withdrew its 2025 guidance, saying market growth in more than 20 states is lower than expected.
Centene withdraws 2025 forecast after review of marketplace risk adjustment
U.S. health insurer Centene said on Tuesday it has withdrawn its 2025 earnings forecast, sending its shares down nearly 22% in extended trading.
Centene (CNC) Loses 5.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
Centene (CNC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.
Looking for Earnings Beat? Buy These 5 Top-Ranked Stocks
Top-ranked stocks Centene (CNC), Astera Labs Inc. (ALAB), Five9 (FIVN), Uber Technologies (UBER) and Voya Financial (VOYA) are likely to beat on the bottom line in their upcoming releases.
Bet on These 4 Stocks With Exciting Interest Coverage Ratio
URBN, STRL, MOH and CNC show strong interest coverage ratios, signaling solid debt management and earnings strength.
Should Value Investors Buy Centene (CNC) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil
As geopolitical risks jolt markets, STNE, CNC, CVS and PFE shine with low cash flow valuations and solid earnings outlooks.
Centene (CNC) Upgraded to Buy: What Does It Mean for the Stock?
Centene (CNC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Centene (CNC) Could be Great Choice for a Bottom Fisher
Centene (CNC) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Centene: Strong Execution And Margin Discipline Support Potential Upside
Centene is a dominant, diversified insurer with strong positions in Medicaid, ACA, and Medicare Part D, serving nearly 29 million members. Q1 2025 results exceeded expectations, with robust revenue growth, improved margins, and management raising full-year revenue guidance. Valuation models indicate a fair value of $60 per share, offering 9% upside; downside risk is limited, and FCF assumptions are conservative.
Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook
STNE, CNC, CVS and PFE stand out as top value picks amid trade tensions and a murky H2 economic outlook.
5 Valuable Price-to-Book Stocks to Strengthen Your Portfolio
The P/B ratio helps to identify low-priced stocks with high growth prospects. CNC, CVS, PFE, STNE and PSFE are some such stocks.
